https://de.marketscreener.com/kurs/aktie/ENTERA-BIO-LTD-40311507/news/Entera-Bio-Ltd-Leitfaden-aus-dem-FDA-Typ-D-Treffen-zum-EB613-Pivotalprogramm-43433016/?utm_source=telegram&utm_medium=social&utm_campaign=share